The physiological roles of tau and Aβ: implications for Alzheimer’s disease pathology and therapeutics
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0533
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The physiological roles of tau and Aβ: implications for Alzheimer’s disease pathology and therapeutics ; volume:140 ; number:4 ; day:29 ; month:7 ; year:2020 ; pages:417-447 ; date:10.2020
Acta neuropathologica ; 140, Heft 4 (29.7.2020), 417-447, 10.2020
- Urheber
-
Kent, Sarah A.
Spires-Jones, Tara L.
Durrant, Claire S.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00401-020-02196-w
- URN
-
urn:nbn:de:101:1-2020110621060063839259
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.04.2025, 16:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kent, Sarah A.
- Spires-Jones, Tara L.
- Durrant, Claire S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Propagation of Tau pathology in Alzheimer disease
Biological mechanisms of resilience to tau pathology in Alzheimer’s disease
Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease
CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease
Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease
Molecular mechanisms of Tau and TDP-43 co-pathology in Alzheimer´s disease
Inhibition of CK2 mitigates Alzheimer’s tau pathology by preventing NR2B synaptic mislocalization
Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer’s disease
Next-generation Alzheimer’s Therapeutics: Leveraging Deep Biology
TGF-β1 signalling in Alzheimer’s pathology and cytoskeletal reorganization: a specialized Tau perspective
Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Propagation of Tau pathology in Alzheimer disease
Biological mechanisms of resilience to tau pathology in Alzheimer’s disease
Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease
CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease
Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease
Molecular mechanisms of Tau and TDP-43 co-pathology in Alzheimer´s disease
Inhibition of CK2 mitigates Alzheimer’s tau pathology by preventing NR2B synaptic mislocalization
Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer’s disease
Next-generation Alzheimer’s Therapeutics: Leveraging Deep Biology
TGF-β1 signalling in Alzheimer’s pathology and cytoskeletal reorganization: a specialized Tau perspective
Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Propagation of Tau pathology in Alzheimer disease
Biological mechanisms of resilience to tau pathology in Alzheimer’s disease
Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease
CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease
Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease
Molecular mechanisms of Tau and TDP-43 co-pathology in Alzheimer´s disease
Inhibition of CK2 mitigates Alzheimer’s tau pathology by preventing NR2B synaptic mislocalization
Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer’s disease
Next-generation Alzheimer’s Therapeutics: Leveraging Deep Biology
TGF-β1 signalling in Alzheimer’s pathology and cytoskeletal reorganization: a specialized Tau perspective
Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease